Real-world efficacy of adjuvant single-agent intravesical gemcitabine for non-muscle invasive bladder cancer
Author:
Affiliation:
1. Department of Urology, University of Iowa, Iowa City, IA, USA
2. Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Jersey, USA
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14656566.2023.2271396
Reference55 articles.
1. Epidemiology and Risk Factors of Urothelial Bladder Cancer
2. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
3. Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment
4. Update on the guideline of guidelines: non-muscle-invasive bladder cancer
5. Emerging intravesical therapies for the management of bacillus Calmette–Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer: Charting a path forward
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synergistic intravesical instillation for bladder cancer: CRISPR-Cas13a and fenbendazole combination therapy;Journal of Experimental & Clinical Cancer Research;2024-08-12
2. Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection;European Urology;2024-08
3. Developments in conservative treatment for BCG-unresponsive non-muscle invasive bladder cancer;Expert Opinion on Pharmacotherapy;2024-07-02
4. Establishing an Intravesical Doublet Chemotherapy Clinic for Nonmuscle-Invasive Bladder Cancer Patients;Urology Practice;2024-07
5. Intravesical sequential gemcitabine/docetaxel for non-muscle invasive bladder cancer: tips and tricks for better efficacy and tolerability;Journal of Chemotherapy;2024-03-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3